Rudolph M Navari (Rudolph Navari, Rudolf M Navari)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Extracorporeal Membrane Oxygenation

Clinical Evaluation

Chemotherapy Induced

Top Venues

Future oncology (London, England)

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Laurent Zelek, Rudolph M Navari, Matti Aapro, Florian Scotte
Single-dose NEPA versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy. Cancer medicine (2023)
Rudolph M Navari, Gary Binder, Erminio Bonizzoni, Rebecca Clark-Snow, Silvia Olivari, Eric J Roeland
Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysis. Future oncology (London, England) 17 (23) (2021)
Sandip Mukhopadhyay, Premnath Dutta, Sanatan Banerjee, Biswamit Bhattacharya, Supreeti Biswas, Rudolph M Navari
Low-dose olanzapine, sedation and chemotherapy-induced nausea and vomiting: a prospective randomized controlled study. Future oncology (London, England) 17 (16) (2021)
Rudolph M Navari, Eric J Roeland
Unscheduled hydrations: redefining complete response in chemotherapy-induced nausea and vomiting studies. Future oncology (London, England) 16 (24) (2020)